According to Nasdaq’s data, the U.S. saw 179 non-SPAC IPOs in 2024 – the most since 2021, and a 40% increase over 2023 (127). By value raised (ex SPACs), it was an even better year, with value raised ...

"Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing" was originally created and published by Medical ...

It was the biggest initial public offering (IPO) in history at the time ... Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

Formed in 2019, Sionna's most recent financing was a $182 million third round that closed last year, which followed a $111 ...

Technology & Telecommunication Acquisition Corp (NASDAQ:TETE), a special purpose acquisition company, has been notified of its pending delisting from the Nasdaq Stock Market due to non-compliance with ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

Nasdaq CEO Adena Friedman is optimistic that President Trump's administration will offer a chance to relook regulations in ...

The carve-out listing is expected to be completed by ... We look forward to welcoming more Nasdaq IPOs in 2025, capitalizing on emerging opportunities in their respective markets,” said Dato ...

In 2024, IPO performance was promising, with most major listings ending the year above their debut prices. Experts, including Eddie Molloy of Morgan Stanley, expect significant activity in ...

Aardvark said it applied to list on the Nasdaq Global Market under the symbol AARD. The company didn't give an expected size for its IPO, nor did it offer an expected price range. Morgan Stanley, B of ...